Ligand Pharmaceuticals Incorporated (LGND)
Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance
Avenue Therapeutics Inc (ATXI)
Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics
Viatris Inc (VTRS)
Viatris Reports Third Quarter 2025 Results and Updates 2025 Financial Guidance
Protalix BioTherapeutics Inc. (PLX)
Protalix BioTherapeutics to Announce Third Quarter 2025 Financial and Business Results on November 13, 2025
Teleflex Incorporated (TFX)
Teleflex Announces Quarterly Dividend
Eli Lilly and Company (LLY)
Lillys selective amylin agonist, eloralintide, demonstrated meaningful weight loss and favorable tolerability in a Phase 2 study of adults with obesity or overweight
Aveanna Healthcare Holdings Inc (AVAH)
Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook
Teleflex Incorporated (TFX)
Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook
Insulet Corporation (PODD)
Insulet Reports Third Quarter 2025 Results
Stevanato Group SpA (STVN)
Stevanato Group Reports Revenue of €303.2 Million for the Third Quarter of 2025